1. Home
  2. SLGN vs KALA Comparison

SLGN vs KALA Comparison

Compare SLGN & KALA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silgan Holdings Inc.

SLGN

Silgan Holdings Inc.

N/A

Current Price

$38.76

Market Cap

5.0B

Sector

Industrials

ML Signal

N/A

Logo KALA BIO Inc.

KALA

KALA BIO Inc.

N/A

Current Price

$0.52

Market Cap

13.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SLGN
KALA
Founded
1987
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
13.3M
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
SLGN
KALA
Price
$38.76
$0.52
Analyst Decision
Strong Buy
Buy
Analyst Count
9
3
Target Price
$52.78
$31.50
AVG Volume (30 Days)
915.0K
353.5K
Earning Date
04-29-2026
04-15-2026
Dividend Yield
2.02%
N/A
EPS Growth
4.65
67.39
EPS
1.31
N/A
Revenue
$4,489,927,000.00
N/A
Revenue This Year
$4.99
N/A
Revenue Next Year
$2.20
N/A
P/E Ratio
$29.31
N/A
Revenue Growth
0.92
N/A
52 Week Low
$35.68
$0.07
52 Week High
$49.41
$20.58

Technical Indicators

Market Signals
Indicator
SLGN
KALA
Relative Strength Index (RSI) 32.53 30.22
Support Level $37.85 $0.10
Resistance Level $38.94 $0.72
Average True Range (ATR) 0.95 0.09
MACD -0.26 0.00
Stochastic Oscillator 13.42 2.92

Price Performance

Historical Comparison
SLGN
KALA

About SLGN Silgan Holdings Inc.

Silgan Holdings Inc is a manufacturer of sustainable rigid packaging solutions for the world's essential consumer goods products. Its products include: dispensing and specialty closures for fragrance and beauty, food, beverage, personal and health care, home care and lawn and garden products; steel and aluminum containers for pet and human food and general line products; and custom designed plastic containers for pet and human food, consumer health and pharmaceutical, personal care, home care, lawn and garden and automotive products.

About KALA KALA BIO Inc.

Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Share on Social Networks: